BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, May 21, 2026
Home » Newsletters » BioWorld MedTech

BioWorld MedTech

July 22, 2020

View Archived Issues
Da Vinci Xi with operating room staff

Intuitive Surgical beats expectations in Q2 despite COVID-19

Robotic-assisted surgery-focused Intuitive Surgical Inc. revealed its second-quarter results late July 21, with worldwide Da Vinci procedures falling about 19% vs. the same period of 2019. Driven by this decline, second quarter 2020 instruments and accessories (I&A) revenue fell by 20% to $461 million, vs. $579 million in the second quarter of 2019. Read More
cybersecurity-data-lock.png

Culture of scientific exchange seen as a risk factor for life science cybersecurity

The U.S. government has charged two citizens of China with cybercrime in connection with purported hacking of research into vaccines for the SARS-CoV-2 virus, but more than one speaker on a July 22 webinar said scientists involved in basic life science research at universities fail to appreciate the need for cybersecurity, a problem they may take with them to the private sector. Read More
U.S., China wrecking balls

Hacking indictment details decade of thefts, ramps up U.S.-China tensions

The alleged activities of two Chinese hackers outlined in a federal indictment unsealed Tuesday offer “concrete examples of two concerning trends,” U.S. Assistant Attorney General John Demers said, as U.S.-China relations further soured with the news of the charges. Read More
Lung cancer illustration

AnchorDx and J&J work on early-stage lung cancer diagnosis in China

Diagnostic firm AnchorDx Medical Co. Ltd. is now working with the Lung Cancer Initiative at Johnson & Johnson in a four-year lung cancer study that aims to enable early detection and diagnosis of the disease in China. The study takes place at six hospitals in the country and is expected to be completed in December 2024. Read More
regulatory-green-light-approved.png

Micro-X gets FDA green light for Rover mobile X-ray for military medical use

PERTH, Australia – The U.S. FDA gave the thumbs up to Australia’s Micro-X Ltd. for its Rover mobile X-ray system. The 510(k) application was cleared in just five weeks. The concept for the Rover was originally developed under a contract with the Australian Department of Defense to prove that Micro-X’s technology could fulfill an unmet need for a full performance, digital medical X-ray imager that was light enough to be used in deployed medical facilities. Read More
Gastrointestinal-microbiome

Exero starts first-in-human trial of wireless, biodegradable GI surgical sensor

Exero Medical Ltd. aims to improve monitoring the gastrointestinal system after surgery with a wireless, biodegradable anastomotic leak sensor implant. It has started a tiny five-patient, first-in-human study as a proof of concept for its technology. Read More

Appointments and advancements for July 22, 2020

New hires and promotions in the med-tech industry, including: Iqvia Holdings, Myriad Genetics. Read More

Financings for July 22, 2020

Med-tech firms raising money in public or private financings, including: Hancock Jaffe Laboratories, Realview Imaging, Renalytix AI, Seer, Tasso. Read More

In the clinic for July 22, 2020

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Roche, Seer, Singlera Genomics, Spineway. Read More

Other news to note for July 22, 2020

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adeptrix, Ait Bioscience, Avacta, Axogen, Biofourmis, Biomerica, Bruker, Cerner, Chugai, Client Outlook, Cureatr, Cure.fit, Echosens, Eko, Hisky, Labvantage Solutions, Luminex, Mach7 Technologies, Nanowear, Nexelis, Newsight Imaging, Novocure, Otogenetics, Qiagen, Swift Sciences, Thermo Fisher Scientific, Twist Bioscience, Zimmer Biomet. Read More

Regulatory actions for July 22, 2020

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Becton Dickinson, Canon Medical, Cerapedics, Integra, X-Nav Technologies. Read More

Regulatory front for July 22, 2020

The latest global regulatory news, changes and updates affecting medical devices and technologies, including: Cordant, MITA. Read More

BioWorld MedTech’s Orthopedics Extra for July 22, 2020

Keeping you up to date on recent developments in orthopedics, including: Spinal stimulators repurposed to restore touch in lost limb; Genetic testing could improve screening for osteoporosis; Study shows genetic markers are useful in predicting osteoporotic fracture risk. Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 20, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 19, 2026
  • Microscopic view of the ebola virus

    WHO declares Ebola outbreak a public health emergency of international concern

    BioWorld
    The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
  • Acid alpha-glucosidase molecular structure isolated on black

    ‘Detargeted’ targeted gene therapy improves activity in Pompe

    BioWorld
    A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
  • Nxera Pharma prepares and tests new GPR17 antagonists

    BioWorld Science
    Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing